FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized
At Bloom, we believe self-care should feel personal, approachable, and empowering
& Potier, M
10.1016/0026-0495(93)90285-V 43 FryburgD
1 ,
i.L-carnitine form (L-carnitine L-tartrate preferred for exercise and fat oxidation, free-form acceptable) ii.Dose per serving aligned with clinical ranges (1,000-3,000 mg/day) iii.Format (liquid for speed, capsule for convenience, both valid at equivalent doses) iv.Supporting ingredients (fucoxanthin, green tea, or other metabolic compounds) v.GMP certification, serving count, and value per serving Our top 6 picks 1